TransCure Biosciences Holding SA

Company founded: December 2011

TransCure Biosciences (TCB) is providing humanized mice for pharmaceutical companies

TransCure Biosciences (TCB) is providing humanized immune system (HIS) mice for pharmaceutical companies and the scientific community as models for immune diseases (e.g. HIV/AIDS, cancer, oter infectious diseases and antibody testing. Moreover, TCB is planning a proof of concept study for a radical cure against HIV. The proposal is originating from scientists of the University/Hospital of Geneva, Pretoria, and Zürich.

Milestones / News

Funding Activity 16.05.2013

Transcure wins the final kick 130'000 CHF
Funding Activity 16.05.2012

Venture Kick (Step 2)
Funding Activity 10.01.2012

Venture Kick (Step 1)
Funding Activity 03.12.2011

Initial capital

Multimedia

TransCure @ Global Pitchfest in Boston

>

TransCure Biosciences Holding SA

Patrick Nef

Avenue de la Roseraie 64
1205 Genève

http://www.transcurebiosciences.com

Contact

Sharing

Links

Support

Awards (2)

A PHILANTHROPIC INITIATIVE OF A PRIVATE CONSORTIUM

Turning scientific innovation into entrepreneurial activity and job creation is the basis of societal and economical prosperity. In the very early stages, startups bear very high risks that are neither carried by public money nor by private investors. Supporting seed stage startups fills a crucial gap and is therefore purely philanthropic.
Read more about the Foundation of Founders